Drug intelligence / Profile preview

fluoroacetic acid F-18

Development stage
Phase 1
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Fluoroacetic acid F-18 is a radiolabeled analog of acetate in which the hydrogen atom at the second position is replaced by radioactive fluorine-18. It is primarily under investigation as a positron emission tomography (PET) imaging agent due to its ability to mimic acetate metabolism and allow visualization of metabolic processes in vivo. The compound has a longer radioactive half-life (approximately 110 minutes for fluorine-18), making it suitable for PET imaging procedures. Its mechanism involves cellular uptake and participation in metabolic pathways similar to natural acetate, enabling detection of tissue metabolism and potentially tumor activity during PET scans[1][2][3]. Fluoroacetic acid F-18 is not currently approved for routine clinical use but has been studied in clinical trials as an investigational diagnostic agent.

Other names
2-fluoroacetic acid F-18[^18F]fluoroacetate
02

Targets

ACO (Aconitase 1)

Beyond the preview

Go deeper on fluoroacetic acid F-18.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluoroacetic acid F-18.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call